GlassScriptPhysician profile
Steven Siwei Yu
NPI 1659643682
$34,431.78
in general payments reported to CMS, 2019-2025
89 companies · $6,462 in 2025
The $6,462 reported for 2025 was more than what 84% of Hematology & Oncology providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,937 · 2020: $3,439 · 2021: $3,854 · 2022: $4,889 · 2023: $5,524 · 2024: $6,328 · 2025: $6,462.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $18K · Education: $16.23.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $18,297.33 |
| Education | $16.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $2,814.05 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $2,060.11 | 2019-2025 | Keytruda, Lynparza, Welireg |
| Astrazeneca Pharmaceuticals LP | $1,866.83 | 2019-2025 | Calquence, Enhertu, Imfinzi |
| E.R. Squibb & Sons, L.L.C. | $1,668.20 | 2019-2025 | Opdivo, Opdualag |
| Incyte Corporation | $1,634.60 | 2019-2025 | Jakafi, Monjuvi, Pemazyre |
| Janssen Biotech, INC. | $1,415.03 | 2019-2025 | Darzalex, Tecvayli, Imbruvica |
| Eisai INC. | $1,388.53 | 2019-2025 | |
| Celgene Corporation | $1,242.58 | 2019-2025 | Reblozyl, Pomalyst, Opdualag |
| Pfizer INC. | $1,221.96 | 2019-2025 | |
| Gilead Sciences, INC. | $1,007.92 | 2019-2025 | Trodelvy |
| Amgen INC. | $999.27 | 2019-2023 | Blincyto, Kyprolis, Lumakras |
| Pharmacyclics LLC, An Abbvie Company | $930.45 | 2019-2023 | Imbruvica, Epkinly |
| Takeda Pharmaceuticals U.S.A., INC. | $930.35 | 2019-2025 | Fruzaqla, Alunbrig, Iclusig |
| Glaxosmithkline, LLC. | $928.06 | 2020-2025 | Ojjaara, Jemperli, Zejula |
| Exelixis INC. | $907.99 | 2019-2025 | Cabometyx |
Show all 89 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Seagen INC. | $856.03 | 2019-2023 | Padcev, Tukysa, Tivdak |
| Genentech USA, INC. | $808.92 | 2019-2025 | Tecentriq, Phesgo, Tecentriq Hybreza |
| Lilly USA, LLC | $776.72 | 2019-2025 | Jaypirca, Verzenio, Retevmo |
| Abbvie INC. | $744.58 | 2020-2025 | |
| Alexion Pharmaceuticals, INC. | $703.13 | 2019-2025 | Ultomiris |
| Daiichi Sankyo INC. | $606.52 | 2022-2025 | Enhertu, Datroway |
| Array Biopharma INC | $505.95 | 2019-2025 | Braftovi, Mektovi, Xalkori |
| Puma Biotechnology, INC. | $502.15 | 2021-2025 | Nerlynx |
| Regeneron Healthcare Solutions, INC. | $497.01 | 2019-2025 | Libtayo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $432.90 | 2019-2025 | Gilotrif |
| Astellas Pharma US INC | $431.84 | 2022-2025 | Xtandi, Padcev, Xospata |
| Genzyme Corporation | $408.29 | 2019-2025 | |
| Karyopharm Therapeutics INC. | $377.62 | 2021-2025 | Xpovio |
| Kite Pharma, INC. | $375.87 | 2020-2024 | Yescarta |
| Aveo Pharmaceuticals, INC. | $348.65 | 2021-2025 | Fotivda |
| Bayer Healthcare Pharmaceuticals INC. | $346.67 | 2023-2025 | |
| Rigel Pharmaceuticals, INC. | $317.42 | 2019-2025 | Rezlidhia, Tavalisse, Tavalisse |
| Stemline Therapeutics INC. | $265.49 | 2019-2025 | Orserdu, Elzonris |
| Blueprint Medicines Corporation | $261.82 | 2022-2025 | Ayvakit |
| Emd Serono, INC. | $231.48 | 2019-2025 | |
| Sobi, INC | $205.32 | 2021-2025 | |
| Beigene USA, INC. | $193.51 | 2022-2025 | Brukinsa, Tevimbra |
| Progenics Pharmaceuticals, INC. | $177.56 | 2023-2024 | Pylarify |
| Adc Therapeutics America, INC. | $172.22 | 2025 | |
| Myovant Sciences INC. | $155.04 | 2022 | |
| Beone Medicines USA, INC. | $138.50 | 2025 | Brukinsa, Tevimbra |
| Deciphera Pharmaceuticals INC. | $137.82 | 2021-2023 | Qinlock |
| Springworks Therapeutics, INC. | $121.96 | 2024-2025 | Ogsiveo |
| Ipsen Biopharmaceuticals, INC | $121.70 | 2019-2025 | Onivyde, Somatuline Depot |
| Pharmaessentia USA Corporation | $119.17 | 2024-2025 | Besremi |
| Foundation Medicine, INC. | $116.83 | 2019-2023 | |
| Recordati_rare_diseases_inc. | $113.43 | 2024-2025 | Enjaymo, Sylvant |
| Jazz Pharmaceuticals INC. | $97.08 | 2019-2025 | Vyxeos |
| Sumitomo Pharma America, INC. | $93.19 | 2024-2025 | Orgovyx |
| Epizyme, INC. | $88.75 | 2021-2022 | |
| Taiho Oncology, INC. | $86.40 | 2022-2025 | |
| Genmab U.S., INC. | $77.56 | 2023-2025 | Epkinly |
| Octapharma USA, INC. | $74.30 | 2021-2023 | Panzyga |
| Servier Pharmaceuticals LLC | $70.45 | 2021-2025 | |
| Organon LLC | $66.57 | 2021-2023 | Ontruzant |
| Verity Pharmaceuticals INC. | $65.24 | 2023 | Trelstar |
| Tersera Therapeutics LLC | $64.41 | 2021-2023 | Quzyttir |
| Coherus Oncology, INC. | $59.58 | 2024-2025 | Loqtorzi |
| Dendreon Pharmaceuticals LLC | $57.54 | 2023-2025 | Provenge |
| Kyowa Kirin, INC. | $54.30 | 2023-2025 | Poteligeo |
| Pharmacosmos Therapeutics INC. | $51.03 | 2020-2025 | Monoferric |
| Dova Pharmaceuticals | $49.98 | 2019-2020 | |
| Boston Scientific Corporation | $49.10 | 2024 | Therasphere Y90 Glass Microspheres 10 Gbq |
| Geron Corporation | $46.55 | 2024-2025 | Rytelo |
| Adaptive Biotechnologies Corporation | $45.06 | 2022 | |
| Fennec Pharmaceuticals, INC. | $43.80 | 2024-2025 | Pedmark, Fyarro |
| Iovance Biotherapeutics, INC. | $42.01 | 2025 | Amtagvi |
| Morphosys, US INC. | $41.02 | 2023 | Monjuvi |
| Clovis Oncology, INC. | $40.96 | 2019 | |
| Amag Pharmaceuticals, INC. | $38.85 | 2020 | |
| Lexicon Pharmaceuticals, INC. | $37.61 | 2019 | |
| Azurity Pharmaceuticals, INC. | $36.91 | 2025 | Danziten |
| Syndax Pharmaceuticals, INC. | $33.49 | 2025 | |
| Sun Pharmaceutical Industries INC. | $30.70 | 2024 | |
| Tempus Ai, INC | $29.49 | 2024 | |
| Ge Healthcare | $26.37 | 2025 | |
| Mirati Therapeutics, INC. | $24.87 | 2024 | Krazati |
| Spectrum Pharmaceuticals INC. | $24.55 | 2025 | Rolvedon |
| Legend Biotech USA INC. | $24.52 | 2025 | Carvykti |
| Mylan Institutional INC. | $24.05 | 2022 | |
| Cti Biopharma Corp. | $22.91 | 2023 | Vonjo |
| Immunogen, INC. | $21.71 | 2023 | Elahere |
| Immunomedics, INC. | $18.07 | 2020 | |
| Hologic Sales and Service, LLC | $17.40 | 2022 | |
| Shorla Oncology INC. | $15.12 | 2025 | |
| Apellis Pharmaceuticals, INC. | $14.70 | 2025 | Empaveli |
| Eusa Pharma (US) LLC | $13.04 | 2019 | |
| Agios Pharmaceuticals, INC. | $12.32 | 2020 | |
| Emmaus Medical, INC. | $12.17 | 2024 | Endari |
Drugs and devices associated with these payments
Keytruda $1,154Enhertu $783Imbruvica $773Lenvima $685Ultomiris $622Darzalex $555Jakafi $494Calquence $493Reblozyl $478Epkinly $448Tecvayli $382Jaypirca $371Cabometyx $361Verzenio $327Lynparza $325Opdivo $310Ojjaara $308Fruzaqla $303Kisqali $292Xtandi $292Libtayo $286Nubeqa $283Trodelvy $252Xpovio $248Pluvicto $248Ibrance $243Talvey $225Imfinzi $225Xofigo $224Tukysa $222Retevmo $221Brukinsa $218Opdualag $218Padcev $216Welireg $211Fotivda $207Tecentriq $206Orserdu $204Ayvakit $201Sarclisa $185Monjuvi $183Nerlynx $183Orgovyx $182Pylarify $178Scemblix $174Braftovi $173Mektovi $173Zynlonta $172Alunbrig $172Tavalisse $170Rezlidhia $170Lutathera $166Fabhalta $162Erleada $159Jemperli $159Pomalyst $150Tagrisso $135Zejula $134Elahere $133Ogsiveo $122Besremi $119Venclexta $116Gilotrif $116Inlyta $112Pemazyre $112Akeega $108Piqray $108Comirnaty $100Talzenna $99.58Adcetris $98.64Keytruda Qlex $97.63Tevimbra $94.66Lorbrena $93.53Carvykti $91.50Rybrevant $91.48Vonjo $90.01Enjaymo $89.89Yescarta $88.47Doptelet $82.24Xalkori $81.10Datroway $80.21Elrexfio $79.14Balversa $75.64Onivyde $74.23Inqovi $71.78Lonsurf $71.78Mekinist $71.67Blenrep $70.39Trelstar $65.24Phesgo $64.94Gavreto $63.46Vitrakvi $63.19Stivarga $63.19Tibsovo $58.10Somatuline Depot $58.00Provenge $57.54Bosulif $56.07Poteligeo $54.30Paxlovid $53.17Xospata $49.12
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Yu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.